Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Increasing trial participation for new cancer treatments

Posted on September 12th, 2022 by

Thanks to new and innovative treatments, cancer survival rates continue to improve dramatically – and this will likely only accelerate in the future. Each news cycle seems to carry a new flurry of good news – whether it’s β€˜New cancer treatment offers hope to patients out of options’ or β€˜How AI in precision medicine is helping find new treatments for brain tumors in children’.

(more…)

Fighting the stigmatization of monkeypox patients

Posted on August 11th, 2022 by

When disease outbreaks occur, health experts are not only faced with the challenge of getting good information out to people – they also must battle misinformation. Rumors fly, people share bits and pieces of articles that they only skimmed, and social media posts full of bad science go viral. Sometimes, when the outbreak begins in a certain locality or hits a particular demographic really hard, they must also contend with the problem of stigmatization – which is now happening with the monkeypox outbreak.

(more…)

Preprints offer early insights into research

Posted on August 9th, 2022 by

To stay competitive in R&D, it is critical to keep abreast of all the latest findings and innovations. Preprints are offering a new way to remain ahead of the curve, allowing a look into new research prior to the peer-review process.

(more…)

Mobilizing against monkeypox

Posted on August 3rd, 2022 by

As the world continues to navigate Covid and its many strains, it would be an understatement to say that everyone is on high alert for other types of outbreaks. Monkeypox is now top of mind, as the disease – first identified in humans in 1970 and mostly found in rainforest areas in Central and West Africa – is now seeing its largest-ever outbreaks outside of the African continent.

(more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 93